DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “North American Ophthalmology Surgery Devices Market – Opportunities and Forecasts, 2014 – 2022” report to their offering. The key factors driving the growth of the North American ophthalmology surgery devices market are rising aging population, increased focus on combination therapies of drugs, increasing prevalence of ocular disorders, and changing geographical trends & demographics. However, economic slowdown
Better Than Drugs: A Diabetes Prevention Program That Works
Matt Longjohn, national health officer of the YMCA, describes the very successful diabetes prevention programs administered through the YMCA and deemed reimbursable by CMS. Medscape Family Medicine
TPG Capital to acquire Beaver-Visitec
TPG Capital has entered into a definitive agreement with RoundTable Healthcare Partners to acquire Beaver-Visitec, according to a RoundTable press release. The transaction will include brands of Beaver blades, Visitec cannulae and instruments, Merocel …
Cigna Launches Brand Campaign for International Markets Based on Real Stories of Ensuring Customer Health, Well-Being and Security
HONG KONG–(BUSINESS WIRE)–Cigna has unveiled its first ever regional brand campaign for key international markets, designed to showcase the company’s capabilities and the solutions it delivers for customers. The campaign, themed “All The Way, Means All The Way,” builds on Cigna’s global wellness mission to improve customers’ health, well-being and sense of security and is being rolled out in an integrated digital marketing format across multiple markets internationally. The series of advertis
As-needed aflibercept resolves persistent, recurrent fluid in eyes with neovascular AMD
As-needed aflibercept injections improved anatomic outcomes in eyes with recurrent or persistent retinal fluid associated with neovascular age-related macular degeneration, a study found.The retrospective study included 81 eyes of 78 patients with pers…
Glaukos Corporation to Release Second Quarter 2016 Financial Results after Market Close on August 1
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, plans to release second quarter 2016 financial results after the market close on Monday, August 1, 2016. The company’s management will discuss the results during a conference call and simultaneous webcast at 1:30 p.m. PDT (4:30 p.m. EDT) on August